Application of compound Haqing injection in preparing drug for treating diseases of respiratory system

Abstract

The invention provides application of a compound Haqing injection in preparing a drug for treating diseases of a respiratory system. The drug is formed by the compound Haqing injection and one or a combination of Ruyi anti-asthma pills and lidocaine. The drug is used for acupoint injection to treat one or multiple diseases of a cold, acute and chronic bronchitis, a chronic obstructive pulmonary disease, emphysema, a pulmonary heart disease, asthmatic bronchitis, bronchopneumonia, interstitial pneumonia and cough variant asthma. It is proved through experimental results of clinical cases that the drug for acupoint injection is significant in curative effect on the diseases of the respiratory system and particularly obvious in curative effect on the diseases such as the chronic obstructive pulmonary disease and cough variant asthma.

Description

technical field [0001] The invention belongs to the field of medicine, and in particular relates to the application of a compound Haqing injection in the preparation of medicines for treating respiratory diseases. Background technique [0002] Respiratory system disease is a common and frequently-occurring disease. The main lesions are in the trachea, bronchi, lungs, and chest cavity. Mild cases often cause coughing, chest pain, and respiratory problems. Severe cases have dyspnea, hypoxia, and even death due to respiratory failure. The death rate in the city is the third, while in the countryside it is the first. What should be paid more attention to is that due to air pollution, smoking, population aging and other factors, chronic obstructive pulmonary disease (referred to as COPD, including chronic bronchitis, emphysema, pulmonary heart disease), bronchial asthma, lung cancer, The morbidity and mortality of diseases such as pulmonary diffuse interstitial fibrosis and pulm...

AI Technical Summary

Problems solved by technology

However, the existing injections have the problems of time-consuming and inconvenient treatment in clinical treatment. Patients often feel pain during intramuscular injection, especially children.

Therefore, patients are not adaptable to intramuscular injection. Secondly, the one-time dosage of intramuscular injection is relatively large, and the probability of adverse reactions also increases.